ASOs function through a mechanism known as antisense technology. When an ASO binds to its complementary RNA sequence, it can recruit RNase H, an enzyme that degrades the RNA strand, thereby preventing the production of the associated protein. Alternatively, ASOs can block ribosomal assembly or splice-site selection, leading to altered protein production. This makes ASOs highly versatile tools in the treatment of genetic disorders.